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ABSTRACT	 	A	simple,	precise,	accurate	and	economical	UV	spectrophotometric	method	has	been	developed	and	vali-dated	 for	 the	 estimation	 of	 Minoxidil	 in	 tablet	 dosage	 form.	 Minoxidil	 shows	maximum	 absorbance	 at	279.4nm.	The	method	was	carried	out	by	using	0.1N	HCl	as	a	solvent.	The	drug	shows	linearity	from	the	concentration	range	of	1-6µg/ml	and	correlation	coefficient	was	found	to	be	0.9992.	The	proposed	method	was	statistically	validated	for	precision,	accuracy,	ruggedness,	robustness,	limit	of	detection,	limit	of	quan-titation	as	per	 the	 ICH	guidelines.	Hence	 this	method	can	be	successfully	applied	 for	 routine	analysis	of	Minoxidil	in	bulk	and	tablet	dosage	form.	
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INTRODUCTION	Chemically	minoxidil	is	2,	4-pyrimidinediamine,	6-(1-piperidinyl)-3-oxide.	 Its	 molecular	 formula	 is	C9H15N5O	and	molecular	weight	is	209.25.	It	is	freely	soluble	in	methanol,	0.1N	HCl,	0.1N	H2SO4,	propylene	glycol	 but	 slightly	 soluble	 in	water.	Minoxidil	 is	 an	orally	 effective	 direct	 acting	 peripheral	 vasodilator	that	 reduces	 elevated	 systolic	 and	 diastolic	 blood	pressure	 by	 decreasing	 peripheral	 vascular	 re-sistance.	The	active	metabolite	of	minoxidil	activates	the	ATP-modulated	potassium	channel	causing	K+	ef-flux,	 hyperpolarization	 and	 smooth	 muscle	 relaxa-tion.	Initially	minoxidil	described	as	an	antihyperten-sive	agent	but	it	also	shows	some	new	applications,	especially	in	the	treatment	of	androgenic	alopecia.	
According	to	the	literature	survey	it	was	found	that	few	analytical	methods	were	reported	for	the	estima-tion	 of	 minoxidil	 by	 using	 UV	 spectroscopy[2].	 The	other	methods	were	also	proposed	for	its	determina-tion	 includes	 HPLC,	 RP-HPLC,	 and	 electrochemical	method	[4,5].	The	present	investigation	is	to	develop	a	simple,	 precise	 and	 cost-effective	 UV	 method	 for	method	development	and	validation	of	minoxidil	in	a	pharmaceutical	dosage	form.					
 
Figure 1: Structure of Minoxidil	
MATERIALS	AND	METHODS	Single	pan	electronics	balance-sartorious	GE412,	UV	visible	double	beam	spectrophotometer	(systronics-2203	smart),	matches	quartz	cells	corresponding	to	1cm	path	length.	Minoxidil	was	taken	as	a	gifted	sam-ple	from	sun	pharmaceuticals	pvt.	Ltd.	and	its	phar-maceutical	dosage	forms	were	purchased	from	mar-ket.	
Reagents:	0.1N	HCl,	Minoxidil,	Reference	standard		
Preparation	of	standard	stock	solution:	The	stand-ard	stock	solution	was	prepared	by	dissolving	25mg	of	drug	in	25ml	of	0.1N	HCl	to	produce	a	1000µg/ml.	From	 the	 above	 solution,	 1ml	 of	 stock	 solution	 is	withdrawn	 and	 diluted	 with	 100ml	 of	 0.1N	 HCl	 to	produce	10µg/ml	concentration.	
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Determination	 of	 ƛmax:	 10µg/ml	 concentration	 of	minoxidil	was	prepared	and	scanned	under	UV	from	250-400nm[9].	 The	 ƛmax	 of	 the	 drug	 was	 found	 at	279.4nm	with	a	sharp	peak.	
 
Figure 2: Determination of ƛmax minoxidil	
Beer’s	law	concentration	range:	The	stock	solution	was	suitably	diluted	with	0.1N	HCl	to	get	a	concentra-tion	range	from	1-6µg/ml	and	their	absorbance	was	measured	at	279.4nm.	Using	 the	absorbance	values	against	concentration,	calibration	curve	was	plotted.	From	 the	 graph	 it	 was	 found	 that,	 Minoxidil	 obeys	beer’s	law	between	1-6µg/ml.	
Table 1: Linearity data for Minoxidil 
S.no Concentration	(µg/ml) Absorbance 1 1 0.196 2 2 0.364 3 3 0.520 4 4 0.685 5 5 0.831 6 6 0.985 Slope =	0.1571 Correlation	coefficient =	0.9992 
 
Figure 3: Linearity graph for Minoxidil	
Preparation	of	 sample	 solution:	 	20	 tablets	were	finely	powdered.	An	accurately	weighed	quantity	of	tablet	powder	equivalent	to	about	25mg	of	Minoxidil	was	transferred	to	25ml	standard	flask.	This	was	di-luted	with	25ml	of	0.1N	HCl	to	give	1000µg/ml.	From	this	 0.2,	 0.3,	 0.4,	 0.5,	 0.6ml	 of	 sample	 solution	was	taken	and	diluted	with	100ml	of	0.1N	HCl	to	give	2,	3,	4,	5,	6µg/ml	concentration.	The	solution	was	filtered	and	 absorbance	 value	 of	 sample	 solutions	was	 rec-orded	at	279.4nm.		
RESULTS	AND	DISCUSSION	Validation	 is	 defined	 as	 the	 establishing	 evidence	which	provide	high	degree	of	assurance	 that	a	 spe-cific	 process	 will	 consistently	 produce	 a	 product	meeting	its	determined	specification	quality	charac-teristics.	 The	 following	parameters	 used	 for	 valida-tion	studies	are	
Precision:	The	 closeness	 of	 agreements	 between	 a	series	of	measurements,	multiple	sampling	of	homog-enous	samples	under	prescribed	condition,	precision	is	of	two	types:	
• Repeatability	
• Reproducibility	
Repeatability	(System	Precision):	4µg/ml	concen-tration	solution	of	Minoxidil	was	prepared	whose	ab-sorbance	 measured	 six	 times	 for	 which	 relative	standard	deviation	was	calculated.	
Reproducibility	(Method	Precision):	Six	individual	preparations	of	Minoxidil	were	prepared	with	a	con-centration	of	4µg/ml,	whose	absorbance	was	meas-ured	at	279.4nm.	
Solution	stability:	4µg/ml	concentration	solution	of	Minoxidil	was	prepared	and	the	solution	whose	ab-sorbance	was	measured	for	every	half	an	hour	for	90	minutes	and	the	solution	were	found	to	be	stable	up	to	90	minutes.	
Limit	of	detection:	The	detection	limit	of	an	individ-ual	analytical	procedure	is	the	lowest	amount	of	ana-lyte	in	a	sample	which	can	be	detected	but	not	neces-sarily	quantitated	as	an	exact	value[13].		
LOD	=	!.!	×	%.&%'()* 	
Table 2: Results for LOD 
S.no.	 Parameter	 Minoxidil	1	 Slope	 0.1601	2	 Standard	deviation	 0.0209	3	 LOD	 0.34202	
Limit	of	quantitation:	The	limit	of	quantitation	of	an	individual	analytical	procedure	is	the	lowest	amount	of	analyte	in	a	sample	which	can	be	quantitatively	de-termined	with	precision	and	accuracy.	
LOQ	=	+,	×	%.&%'()* 	
Table 3: Results for LOQ 
S.no.	 Parameter	 Minoxidil	1	 Slope	 0.1601	2	 Standard	deviation	 0.0209	3	 LOQ	 1.14040	
Accuracy:	Accuracy	of	method	is	the	closeness	of	the	measured	value	to	the	true	value	for	the	sample.	Ac-curacy	is	usually	determined	by	recovery	studies.	
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Recovery	studies	are	performed	by	spiking	pure	pow-dered	drug	into	the	sample	solution.	The	spiked	sam-ples	are	prepared	at	a	 concentration	 range	of	80%,	100%,	120%.	
Procedure:	The	sample	solution	was	prepared	to	get	a	 concentration	 range	 of	 3µg/ml,	 4µg/ml,	 5µg/ml,	into	which	5mg	of	pure	powdered	drug	was	added	to	get	80%,	100%,	120%	concentration	range.	The	per-centage	recovery	was	calculated	for	these	concentra-tions	from	absorbance	obtained.	The	percentage	recovery	was	calculated	by	using	the	following	formula;	
Percentage	recovery	=	-./012	/32-4156-./012	-6656 	×	100	
The	percentage	recovery	for	the	spiked	preparation	should	be	within	98-102	%.	
Ruggedness:	The	extent	to	which	is	turned	precision	should	 be	 established	 depends	 on	 circumstances	which	the	procedure	is	intended	to	be	used.	Interme-diate	precision	expresses	with	in	laboratory	variation	i.e.,	 different	 days,	 different	 analyst	 and	 different	equipments.	
Procedure:	The	 procedure	 followed	 for	 this	 is	 the	same	followed	in	the	method	precision	was	repeated	on	two	different	days	by	two	different	analysts.	The	result	for	the	intermediate	precision	recorded	in	the	table.	
Table 4: Results for formulation Lonitab 5mg 
S.no.	 Conc	(µg/ml)	 Label	claim	(mg)	 Amount	present	 %	of	label	claim	 %	Dev	1	 2	 5	 0.00503	 98.6	 0.014	2	 3	 5	 0.00505	 99.0	 0.010	3	 4	 5	 0.00503	 98.6	 0.013	4	 5	 5	 0.00500	 98.0	 0.019	5	 6	 5	 0.005064	 99.2	 0.007	
Table 5: Results for formulation dilminox 5mg 
S.no.	 Conc	(µg/ml)	 Label	claim	(mg)	 Amount	present	 %	of	label	claim	 %	Dev	1	 2	 5	 0.00505	 98.9	 0.011	2	 3	 5	 0.00509	 99.8	 0.002	3	 4	 5	 0.00508	 99.6	 0.005	4	 5	 5	 0.00509	 99.5	 0.005	5	 6	 5	 0.0050	 99.4	 0.006	
Table 6: Results for System Precision 
S.no.	 Conc	(µg/ml)	 System	Precision	 Method	Precision	Absorbance	 Absorbance	1	 4	 0.658	 0.566	2	 4	 0.605	 0.565	3	 4	 0.634	 0.585	4	 4	 0.512	 0.570	5	 4	 0.576	 0.607	6	 4	 0.666	 0.599	Average	 0.6085	 0.5824	Standard	deviation	 0.0579	 0.0179	%	RSD	 0.0952	 0.0308	
Table 7: Results of %Recovery Studies 
S.no.	 Concentration	(µg/ml)	 Mg	found	 Mg	added	 %	recovery	1	 80	 0.004952	 0.005	 99.03	2	 100	 0.004993	 0.005	 99.85	3	 120	 0.004903	 0.005	 98.06	
Table 8: Ruggedness Parameters 
Analyte	 Concentration	(µg/ml)	 Absorbance	 %	RSD	Analyte	–	1	 4	 0.5869	 0.0305	Analyte	–	2	 4	 0.5824	 0.0308	
Table 9: Ruggedness Parameters 
Analyte	 Concentration	(µg/ml)	 Absorbance	 %	RSD	Analyte	–	1	 4	 0.5869	 0.0305	Analyte	–	2	 4	 0.5824	 0.0308	
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Acceptance	 Criteria:	 The	 relative	 standard	 devia-tion	for	the	preparation	should	not	be	more	than	2%.	
Robustness:	Robustness	of	the	method	is	its	ability	to	remain	unaffected	by	small	ranges	in	parameters	such	 as	 changes	 in	 wavelength,	 changes	 in	 pH,	changes	in	the	temperature	etc.	Robustness	 examines	 the	 effect	 of	 operational	 pa-rameters	on	the	analytical	method.	
Procedure:	4µg/ml	 concentration	of	Minoxidil	was	prepared.	Absorbance	was	measured	at	two	different	wavelengths	closer	to	the	ƛmax	of	the	drug.	
Table 10: Robustness Results S.no. Concentration	(µg/ml) Wavelength	(nm) Absorb-ance 1 4 277.4 0.583 2 4 279.4 0.588 3 4 281.4 0.599 No	change	in	absorbance	value	
CONCLUSION	On	the	basis	of	our	experimental	results,	we	conclude	that	 the	 UV	 spectrophotometric	 method	 developed	for	 the	determination	of	minoxidil	was	 found	 to	be	precise,	 accurate	 and	 cost	 effective.	 Hence	 this	method	can	be	used	for	routine	analysis	of	Minoxidil	in	bulk	and	pharmaceutical	dosage	forms.	
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